Central nervous system toxicity associated with liposomal amphotericin B therapy for cutaneous leishmaniasis

Jessie S Glasser1, Clinton K Murray

  • 1US Infectious Disease Service, Brooke Army Medical Center, 3851 Roger Brooke Drive, Fort Sam Houston, TX 78234, USA. Jessie.glasser@amedd.army.mil

Insights

Liposomal amphotericin B, used for fungal and leishmaniasis infections, can cause temporary cognitive issues like memory loss and confusion. This side effect may occur even in healthy individuals without other health problems.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Neurology

Background:

  • Liposomal amphotericin B (AmBisome) is a key antifungal and antileishmanial agent.
  • Neurologic toxicities are listed as potential side effects, but specific case reports are rare, especially in healthy patients.
  • Cutaneous leishmaniasis is treated with AmBisome, particularly in endemic regions or for military personnel deployed in such areas.

Observation:

  • A healthy 38-year-old male developed memory difficulties and confusion after completing a course of liposomal amphotericin B for cutaneous leishmaniasis.
  • No other cause for the cognitive symptoms was identified.
  • The patient's symptoms resolved spontaneously within weeks.

Findings:

  • This case suggests that liposomal amphotericin B can cause reversible cognitive side effects, such as memory impairment and confusion.
  • The observed toxicity occurred in a patient without comorbidities, highlighting a potential risk even in healthy populations.
  • The resolution timeline aligns with the known pharmacokinetic profile of liposomal amphotericin B.

Implications:

  • Clinicians should be aware of the potential for cognitive side effects with liposomal amphotericin B, even in immunocompetent patients.
  • Early recognition and monitoring of neurologic symptoms are important during and after treatment.
  • Further research may be warranted to fully characterize the incidence and risk factors for AmBisome-associated neurotoxicity.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Local Anesthetics: Adverse Effects01:12

Local Anesthetics: Adverse Effects

While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...